Mark Jacobson | executive |
Herriot Tabuteau | executive |
Nick Pizzie | executive |
Lori Englebert | executive |
Charles Duncan | analyst |
Marc Goodman | analyst |
Vikram Purohit | analyst |
David Amsellem | analyst |
Jason Gerberry | analyst |
Hunter Murdock | executive |
Joon Lee | analyst |
Raghuram Selvaraju | analyst |
Joseph Thome | analyst |
Yatin Suneja | analyst |
Graig Suvannavejh | analyst |
Myles Minter | analyst |
Matthew Kaplan | analyst |
Good morning, and welcome to Axsome Therapeutics Third Quarter 2023 Financial Results Conference Call. [Operator Instructions].
As a reminder, today's conference is being recorded.I would now like to turn the conference over to your host, Mark Jacobson, Chief Operating Officer, Axsome Therapeutics. Thank you. Please go ahead.